<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220630055330N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-10-25</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>The effects of group-based education of handling skills for parents with children with cerebral palsy on family empowerment and child’s functional mobility</public_title>
      <acronym></acronym>
      <scientific_title>The effects of group-based education of handling skills for parents with children with cerebral palsy on family empowerment and child’s functional mobility</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-07-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>46</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/64534</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: We plan to divide people based on the score of the GMFCS questionnaire into three categories with scores 1 and 2, with score 3 and with scores 4 and 5, and then to perform randomization in a way to select a number of samples from each of these categories almost equally in the intervention and control groups.
First, by drawing a two-by-two table, we specify all the placement situations of the samples in the final groups: 1) intervention/control 2) control/intervention 3) intervention/intervention/control/control. Then, by lottery, one of these arrangement methods is selected and we exceed to the next step.
In the next step, the ID of all the samples in the form of a code along with their GMFCS questionnaire scores are written on separate sheets and arranged randomly. Then in three envelopes (based on the scores of the GMFCS questionnaire, which had three categories with scores 1 and 2, with score 3 and with scores 4 and 5), on the sheets of the sorting system that was determined earlier (for example, intervention/intervention/control/control) In the same way, it is written separately and repetitively and placed inside triple envelopes.
Then the sheets related to the ID of the samples (which apart from their ID code, also includes their GMFCS score) are revealed in order, and based on their GMFCS scores, we go to the desired envelope and take out the sorted sheets from inside it. Based on the writing on the pages inside the envelope (intervention or control), the target sample is randomly placed in one of the intervention or control groups, Blinding description: The evaluator will not know which group each sample belongs to in all stages of the evaluation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Cerebral Palsy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The members of this group, while receiving common occupational therapy interventions including active and passive stretching exercises to improve range of motion and adjust muscle tone, facilitate gross and fine movement patterns in the form of developmental patterns and facilitate the child's movement functions with purposeful activities, they also benefit from 5 related workshop sessions in case of increasing family awareness of their child's condition and training appropriate techniques for handling and positioning him, the content of which is described in detail below. The first group session: During this one-hour session, the researcher will provide information on the nature of cerebral palsy, its causes, types and symptoms of each, functional levels, prognosis and related disorders, in addition to the introduction of drugs used to reduce spasticity and control convulsions and occupational therapy common interventions, through PowerPoint. The second group session: In this session, the researcher guides the parents to discuss and exchange opinions about the handling problems of their children, their musculoskeletal pain, the decrease in the quality of life of parents due to the child's illness, the decrease in the quality of the parent's health, the disruption of their occupational balance and related topics. The third group session: this session will be about children's functional problems in general; In this way, first the researcher explains the areas of occupational performance in the form of PowerPoint, and then parents are invited to express their challenges and the child's challenges in the introduced areas. 4th and 5th group session: By analyzing the discussions of the previous three group sessions that have been explained up to this point, the researcher has identified the basic problems that families are facing and prepares interventions for group training to parents in the form of PowerPoint, which will be presented in the fourth and fifth group sessions. It should be noted that there will be a suitable platform for discussion and exchange of parent's opinions, just like the previous group sessions. Intervention 2: Control group: The members of this group receive common occupational therapy interventions, including active and passive stretching exercises to improve the range of motion and adjust muscle tone, facilitate gross and fine movement patterns in the form of developmental patterns, and facilitate the child's movement functions with purposeful and appropriate activities. The duration of providing common occupational therapy interventions commonly between the intervention and control groups will be 2 months (2 sessions per week and 45 minutes per session).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Pooya Reaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 3, No. 3, 3rd Piroozi Alley, Nikzare Ave., 22nd Bahman Ave., Ashrafi Esfahani Blvd., Bagh Feiz</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1473178434</zip>
        <telephone>+98 21 4442 3675</telephone>
        <email>pooya369@yahoo.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Malek Amini</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation Science, Madadkaran St., Shahid Shah Nazari St., Mother Square, Mirdamad Blvd.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913487</zip>
        <telephone>+98 21 2222 8051</telephone>
        <email>amini.m@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The child has been diagnosed with spastic cerebral palsy by a neurologist
The child does not have vision problems
The child's family does not intend to perform any surgery during the implementation of interventions
The mother of the child can be present as a parent of the participant in the study
The mother (participant's parent) must be fluent in Persian and able to read</inclusion_criteria>
      <agemin>3 years</agemin>
      <agemax>10 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The age of the child is less than 3 years or more than 10 years.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G80</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Cerebral palsy</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The members of this group, while receiving common occupational therapy interventions including active and passive stretching exercises to improve range of motion and adjust muscle tone, facilitate gross and fine movement patterns in the form of developmental patterns and facilitate the child's movement functions with purposeful activities, they also benefit from 5 related workshop sessions in case of increasing family awareness of their child's condition and training appropriate techniques for handling and positioning him, the content of which is described in detail below. The first group session: During this one-hour session, the researcher will provide information on the nature of cerebral palsy, its causes, types and symptoms of each, functional levels, prognosis and related disorders, in addition to the introduction of drugs used to reduce spasticity and control convulsions and occupational therapy common interventions, through PowerPoint. The second group session: In this session, the researcher guides the parents to discuss and exchange opinions about the handling problems of their children, their musculoskeletal pain, the decrease in the quality of life of parents due to the child's illness, the decrease in the quality of the parent's health, the disruption of their occupational balance and related topics. The third group session: this session will be about children's functional problems in general; In this way, first the researcher explains the areas of occupational performance in the form of PowerPoint, and then parents are invited to express their challenges and the child's challenges in the introduced areas. 4th and 5th group session: By analyzing the discussions of the previous three group sessions that have been explained up to this point, the researcher has identified the basic problems that families are facing and prepares interventions for group training to parents in the form of PowerPoint, which will be presented in the fourth and fifth group sessions. It should be noted that there will be a suitable platform for discussion and exchange of parent's opinions, just like the previous group sessions.</i_keyword>
      <i_keyword>Control group: The members of this group receive common occupational therapy interventions, including active and passive stretching exercises to improve the range of motion and adjust muscle tone, facilitate gross and fine movement patterns in the form of developmental patterns, and facilitate the child's movement functions with purposeful and appropriate activities. The duration of providing common occupational therapy interventions commonly between the intervention and control groups will be 2 months (2 sessions per week and 45 minutes per session).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Family empowerment score in the Family Empowerment Scale. Timepoint: Measuring family empowerment score for the first time at the beginning of the study, for the second time one month after the start of the study, for the third time two months after the start of the study (at the end of the interventions), for the fourth time one month after the end of the interventions and for the fifth time two months after the end  of the Interventions. Method of measurement: Family Empowerment Scale.</prim_outcome>
      <prim_outcome>Gross motor function score in the Gross Motor Function Measurement. Timepoint: Measuring Gross motor function score for the first time at the beginning of the study, for the second time one month after the start of the study, for the third time two months after the start of the study (at the end of the interventions), for the fourth time one month after the end of the interventions and for the fifth time two months after the end  of the Interventions. Method of measurement: Gross Motor Function Measurement - 88.</prim_outcome>
      <prim_outcome>Functional mobility score in the Mobility subscale of the Pediatric Evaluation of Disability Inventory. Timepoint: Measuring Functional mobility score for the first time at the beginning of the study, for the second time one month after the start of the study, for the third time two months after the start of the study (at the end of the interventions), for the fourth time one month after the end of the interventions and for the fifth time two months after the end  of the Interventions. Method of measurement: Mobility subscale of the Pediatric Evaluation of Disability Inventory.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-06-21</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Science</contact_name>
        <contact_address>Unit 3, No. 3, 3rd Piroozi Alley, Nikzare Ave., 22nd Bahman Ave., Ashrafi Esfahani Blvd., Bagh Feiz Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
